| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Roth Byron | Director | C/O ACUREN CORPORATION, 14434 MEDICAL COMPLEX DRIVE, SUITE 100, TOMBALL | /s/ MaryJo Obrien, Attorney-in-Fact | 06 Aug 2025 | 0001810078 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TIC | Restricted Stock Units | Award | $0 | +9,524 | $0.000000 | 9,524 | 04 Aug 2025 | Common Stock | 9,524 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. |
| F2 | These restricted stock units vest on August 4, 2026 (the one-year anniversary of the grant date). |